SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Jane Austen — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJane Austen
Date of birth1775-12-16
IdentifiersMRN HR-EN014-SYN-TD; SSN (made up) 000-14-6317
Document date1816-04-02
AuthorHarriet Pemberton-Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Two-week review after starting replacement: electrolytes, cause, and autoimmune screening. [S]

History of Present Illness

Ms. Austen returns two weeks after starting hydrocortisone and fludrocortisone. She has missed no doses. Within three days the morning nausea stopped and her appetite returned, and she now eats three meals a day. The lightheadedness on standing has almost gone, and the salt craving is less. She is still tired by late afternoon but has started writing again for an hour each morning. Her back ache is milder. She has practised with the trainer kit and can recite the sick-day rules. She has not yet ordered the medical ID. [S]

ElementDetail
ReplacementHydrocortisone 10 mg on waking and 5 mg at 2 pm; fludrocortisone 0.1 mg; no missed doses
SymptomsNausea gone; appetite back; afternoon tiredness; milder back ache
Weight53.4 kg, up 1.6 kg

Review of Systems

SystemResultFinding
ConstitutionalPositiveTired by late afternoon; appetite good; no fevers or night sweats
CardiovascularNegativeNo lightheadedness, palpitations, or ankle swelling
GastrointestinalNegativeNo nausea, vomiting, or abdominal pain
MusculoskeletalPositiveMild low back ache by evening
GenitourinaryNegativePeriods regular

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrocortisone 10 mg oral tablet, one tablet by mouth on wakingOne tablet by mouth on wakingOral route1816-03-19activeS
Hydrocortisone 5 mg oral tablet, one tablet by mouth at 2 pmOne tablet by mouth at 2 pmOral route1816-03-19activeS
Fludrocortisone 0.1 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morningOral route1816-03-19activeS
Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911Once, as needed for adrenal crisis; carry at all timesIntramuscular route1816-03-19activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1816-04-02Body height170cmS
1816-04-02Body weight53.4kgS
1816-04-02Body mass index (BMI) [Ratio]18.5kg/m2S
1816-04-02Systolic blood pressure108mm[Hg]S
1816-04-02Diastolic blood pressure68mm[Hg]S
1816-04-02Heart rate80/minS
1816-04-02Respiratory rate14/minS
1816-04-02Body temperature36.8CelS
1816-04-02Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1816-04-02Sodium [Moles/volume] in Serum or Plasma137mmol/L135-145 mmol/LNormalS
1816-04-02Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
1816-04-02Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.57-1 mg/dLNormalS
1816-04-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1811)/1.73 sq M88mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1816-04-02Glucose [Mass/volume] in Serum or Plasma88mg/dL70-139 mg/dLNormalS
1816-04-02Hemoglobin [Mass/volume] in Blood11.9g/dL12-15.5 g/dLLowS
1816-04-02Eosinophils [#/volume] in Blood0.3810*3/uL0-0.5 10*3/uLNormalS
1816-04-0221-Hydroxylase Ab [Units/volume] in Serum24U/mLBelow 1 U/mL: negativeHighS
1816-04-02Hemoglobin A1c/Hemoglobin.total in Blood5%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
1816-04-02Tissue transglutaminase IgA Ab [Units/volume] in Serum0.8U/mLBelow 4 U/mL: negativeNormalS
1816-04-02IgA [Mass/volume] in Serum or Plasma188mg/dL70-400 mg/dLNormalS

Physical Exam

Vital signs recorded on 1816-04-02; see the Vital Signs section. [S]

SystemFinding
GeneralBrighter; weight 53.4 kg; blood pressure 108/68 seated
Skin and mouthPigmentation of the face, hands and gums unchanged so far
Lymph nodesNo palpable nodes
AbdomenNo enlarged liver or spleen
ExtremitiesNo ankle edema

Problems

ProblemClinical statusVerificationCodeProvenance
About three months of increasing tiredness, loss of 5 kg, darkening of the skin, nausea with bouts of vomiting, low back ache, salt craving and lightheadedness on standing, with low sodium, high potassium and raised eosinophils; adrenal insufficiency suspected and urgent endocrinology testing bookedresolvedconfirmed R53.83S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the consultation; its timing echoes the documented break in her health (D).
Primary adrenal insufficiency (Addison's disease): no cortisol response to cosyntropin with a markedly raised ACTH, and mineralocorticoid deficiency with raised renin and low aldosterone; on hydrocortisone and fludrocortisone; synthetic modern diagnosis chosen for a historical illness whose cause is disputedactiveconfirmed E27.1S — Synthetic modern diagnosis; the historical cause of her illness remains undetermined (R, disputed).
Mild normocytic anemia (hemoglobin 11.4 g/dL) with normal ferritin, vitamin B12 and folateactiveconfirmed D64.9S — Synthetic finding at intake; it recovers on replacement.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationGlucocorticoid dose: weight, energy, appetite, skin pigmentation, and signs of under- or over-replacementEvery visitCompleted todayWeight 53.4 kg, up 1.6 kg; appetite back; no signs of over-replacement; eosinophils 0.38 x10^3/uL, normal
ExaminationBlood pressure lying and standingEvery visitDeferredMissed: blood pressure was taken seated only (108/68). No harm judging by her symptoms and electrolytes today and by the six-week visit, when there was no postural drop. Corrective action: lying and standing blood pressure added to her visit template
LaboratoryMineralocorticoid: salt craving, edema, sodium and potassiumBefore treatment, after any fludrocortisone change, then at least yearlyCompleted todaySodium 137, potassium 4.6 mmol/L; creatinine 0.86 mg/dL, eGFR 88; glucose 88 mg/dL
LaboratoryPlasma renin activity (with aldosterone at diagnosis)At diagnosis; after any fludrocortisone change; then at least yearly, aiming for the upper normal rangeDueSix weeks after starting fludrocortisone
Self-managementSick-day rules, emergency injection kit, steroid card, and medical IDEvery visitCompleted todayRules stated back; practice injection on the trainer; kit and card with her; medical ID ordered today
LaboratoryCause: 21-hydroxylase antibodies; adrenal CT and tuberculosis testing if negativeOnce, at diagnosisCompleted todayPositive (24 U/mL): autoimmune adrenalitis; no adrenal imaging or tuberculosis testing needed
ExaminationDifferential for lymphoma: weight, fevers and night sweats, lymph nodes and spleen, LDH, chest X-rayAt diagnosis, then each visit until symptoms and weight have recovered on replacementCompleted todayWeight rising; no fevers or night sweats; no nodes or enlarged spleen
LaboratoryAssociated autoimmune disease: TSH, vitamin B12, A1c, celiac serology, and menstrual historyAt diagnosis, then TSH and the others yearly or with symptoms; FSH if periods changeCompleted todayA1c 5.0%; tissue transglutaminase IgA 0.8 U/mL with total IgA 188 mg/dL; TSH and vitamin B12 normal at the first visit; periods regular: no associated disease found
LaboratoryBlood count for the normocytic anemia (with ferritin, vitamin B12 and folate at work-up)Work-up at diagnosis; repeat after the underlying cause is treated (CMID); stop once normalCompleted todayHemoglobin 11.9 g/dL, rising

Goal progress:

Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023)

Follow-up: Six-week visit with electrolytes, creatinine, renin, blood count, and lying and standing blood pressure. Follow the sick-day rules for any fever. Next scheduled visit 1816-04-30: six-week review: electrolytes, renin, blood count, and recovery. [S]